CorMedix Inc.·4

Apr 3, 4:30 PM ET

Lefkowitz Steven W 4

4 · CorMedix Inc. · Filed Apr 3, 2025

Insider Transaction Report

Form 4
Period: 2025-04-02
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-02$4.03/sh+20,000$80,600120,498 total
  • Exercise/Conversion

    Stock Option (Right to Buy Common Stock)

    2025-04-0220,0000 total
    Exercise: $4.03Exp: 2032-02-22Common Stock (20,000 underlying)
Holdings
  • Common Stock

    (indirect: Wade Capital Corporation Money Purchase Plan)
    30,152
  • Common Stock

    (indirect: By Spouse)
    2,000
Footnotes (3)
  • [F1]The Reporting Person acquired stock through the exercise of options granted on 02/22/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made.
  • [F2]The Reporting Person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which the Reporting Person has voting and investment control).
  • [F3]These stock options, representing a right to purchase 20,000 shares of Common Stock, were granted on 02/22/2022. These stock options are fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary